Exosome Technologies Market Size, Share, Trends, Report 2022-2030

According to report study, the global exosome technologies market valued at US$ 31 Mn in 2020 and projected to hit US$ 300 million by 2030, expanding growth at a CAGR of 23.5% from 2021 to 2030.

Exosomes are extracellular vehicles secreted from human body cells. Exosomes play a crucial role in the intercellular transportation of protein and RNA. Recently, exosomes have been tested for numerous therapeutic applications, including biomarkers, drug delivery systems, and therapies for diseases such as cancer, renal neurological, and cardiovascular diseases. Increase in awareness about exosome technologies & government initiatives are the key factors projected to drive the global exosome technologies market during the forecast period.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38178

Rise in Prevalence of Chronic Diseases to Drive Global Market

The prevalence of cardiovascular diseases has increased across the globe due to change in dietary habits. According to Centers for Disease Control and Prevention statistics, heart diseases account for nearly 655,000 deaths in the U.S. each year. Cancer is also a leading cause of death globally, caused due to lifestyle-related factors such as alcohol consumption, tobacco consumption, and some food-related factors. According to the World Health Organization statistics, in 2018, an estimated 18.1 million new cases of cancer and 9.6 million deaths were reported across the globe. Aging is considered a major risk factor for neurodegenerative diseases. Therefore, a surge in the geriatric population contributes to the increase in the number of patients with various brain diseases. Moreover, changing environmental conditions and human behavior affect the spread and impact of infectious diseases. Therefore, rise in prevalence of various chronic diseases is likely to boost the global exosomes technologies market during the forecast period.

Scope of The Report

Report Coverage	Details
Market Size By 2030	USD 300 Million
CAGR from 2022 to 2030	23.5%
Largest Market	North America
Fastest Growing Region	Asia Pacific
Base Year	2021
Forecast Data	2022 to 2030
Key Players	Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Ciloa SAS, Codiak BioSciences, Creative Biolabs, Danaher Corporation (Beckman Coulter), Direct Biologics and others.

 

Exosomes Possess Huge Potential in Field of Cancer Immunotherapy

Cell-derived nanovesicles also known as exosomes have the potential to increase clinical outcomes in cancer immunotherapy, owing to their advantageous immunogenicity and molecular transfer function. Companies in the exosome technologies market are adopting proprietary manufacturing platforms to develop EVs that help to regulate immune responses. They are boosting their production capabilities to develop exosomes that are derived from tumor cells and immune cells, which exhibit unique composition profiles that are directly linked with anti-cancer immunotherapy.

Exosomes hold promising potentials to deliver their cargoes to targeted cells and influence the phenotype and immune-regulation functions of targeted cells. Thus, companies in the exosome technologies market are gaining awareness that exosomes have huge potential in the field of cancer immunotherapy.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38178

Exosomes Regulate CVD Progression via Exchange of Signal Molecules

Exosomes, also known as extracellular vesicles with a lipid bilayer membrane of endosomal origin have become the focus of a large body of research in cardiovascular diseases (CVD) for companies in the exosome technologies market. These EVs serve as carriers for signal molecules responsible for intracellular and inter-organ communication underlying CVD pathophysiology. Moreover, they help to overcome limitations of the stem cell therapy, since exosomes released by progenitor cells are bioactive and act as key mediators for the stem cell therapy of CVD.

Exosomes play a critical role in cardiovascular pathophysiology, as they help to regulate CVD progression via transport and exchange of signal molecules. For instance, exosomes released by cardiac fibroblasts rescue cardiomyocytes from ischemia-reperfusion injury. 

Report Highlights

In terms of exosome type, the global exosome technologies market has been bifurcated into loaded cargo and non-cargo. The loaded cargo segment dominated the market in 2020. Exosomes carry various types of proteins, lipids, and nucleic acids (mRNA and non-coding RNA). Exosomes with therapeutic cargo help to cross the natural membranous barriers, such as the blood-brain barrier (BBB), to achieve better therapeutic efficiency of brain diseases. This, in turn, is projected to drive the segment.

Based on cell source, the global exosome technologies market has been classified into HEK293, MSCs, platelets, erythrocytes, natural killer cells (NKs), and others. The MSCs segment dominated the global exosome technologies market in 2020, and the trend is anticipated to continue during the forecast period. MSCs have immunomodulatory properties to regulate various cells involved in immune responses and exhibit potent cell therapeutics for various diseases for the last few decades. This factor is expected to propel the segment.

In terms of indication, the global exosome technologies market has been categorized into therapeutics and diagnostics. The diagnostics segment held major share of the global exosome technologies market in 2020. The segment’s dominance can be attributed to reimbursement, availability, and approval of new exosome diagnostics products.

Based on end user, the global exosome technologies market has been divided into healthcare providers, pharmaceutical & biotechnology companies, and others. The healthcare providers segment held a major share of the global exosome technologies market in 2020. The segment’s dominance can be attributed to the increase in the geriatric population suffering from various diseases.

North America is projected to account for prominent share of the global exosome technologies market during the forecast period. Extensive in-house manufacturing & research capacity, large customer base, and a well-established healthcare infrastructure are the major factors driving the market in North America. 

The market in Europe is anticipated to expand at a high CAGR in the near future, owing to strategies adopted by key players and grants of patent for exosomes in the region. 

The exosome technologies market in Asia Pacific is projected to grow at a rapid pace in the near future. This can be attributed to government initiatives to improve healthcare infrastructure. For instance, the Government of Japan and a team of industry players announced a collaboration leveraging exosomes to improve cancer diagnosis and its treatment.

Key Players

Key players operating in the global exosome technologies market are Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Ciloa SAS, Codiak BioSciences, Creative Biolabs, Danaher Corporation (Beckman Coulter), Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, Exopharm, Exosome Diagnostics, Inc. (BIO-TECHNE CORPORATION), Fujifilm, ILIAS Biologics, Inc., Illumina, Inc., Invitrix Therapeutics, XOStem, Inc., VivaZome Therapeutics Pty Ltd., Thermo Fisher Scientific, Inc., Organicell, OmniSpirant Ltd., and Novadip Biosciences.

Market Segmentation

By Exosome Type

• Loaded Cargo
  • Peptide
  • siRNA
  • mRNA
  • Protein
  • Chemical
  • Others
• Non-cargo

By Cell Source

• HEK293
• MSCs
• Platelets
• Erythrocytes
• Natural Killer Cells (NKs)
• Others

By Indication

• Therapeutics
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Cosmetics
  • Others
• Diagnostics

By End User

• Healthcare Providers
• Pharmaceutical & Biotechnology Companies
• Others

By Region

• North America
• Europe
• Asia Pacific          
• Latin America
• Middle East & Africa

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38178

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333

 

Exosomes are extracellular vehicles secreted from human body cells. Exosomes play a crucial role in the intercellular transportation of protein and RNA. Recently, exosomes have been tested for numerous therapeutic applications, including biomarkers, drug delivery systems, and therapies for diseases such as cancer, renal neurological, and cardiovascular diseases. Increase in awareness about exosome technologies & government initiatives are the key factors projected to drive the global exosome technologies market during the forecast period.

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38178

Rise in Prevalence of Chronic Diseases to Drive Global Market

The prevalence of cardiovascular diseases has increased across the globe due to change in dietary habits. According to Centers for Disease Control and Prevention statistics, heart diseases account for nearly 655,000 deaths in the U.S. each year. Cancer is also a leading cause of death globally, caused due to lifestyle-related factors such as alcohol consumption, tobacco consumption, and some food-related factors. According to the World Health Organization statistics, in 2018, an estimated 18.1 million new cases of cancer and 9.6 million deaths were reported across the globe. Aging is considered a major risk factor for neurodegenerative diseases. Therefore, a surge in the geriatric population contributes to the increase in the number of patients with various brain diseases. Moreover, changing environmental conditions and human behavior affect the spread and impact of infectious diseases. Therefore, rise in prevalence of various chronic diseases is likely to boost the global exosomes technologies market during the forecast period.

Scope of The Report

Report Coverage	Details
Market Size By 2030	USD 300 Million
CAGR from 2022 to 2030	23.5%
Largest Market	North America
Fastest Growing Region	Asia Pacific
Base Year	2021
Forecast Data	2022 to 2030
Key Players	Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Ciloa SAS, Codiak BioSciences, Creative Biolabs, Danaher Corporation (Beckman Coulter), Direct Biologics and others.

 

Exosomes Possess Huge Potential in Field of Cancer Immunotherapy

Cell-derived nanovesicles also known as exosomes have the potential to increase clinical outcomes in cancer immunotherapy, owing to their advantageous immunogenicity and molecular transfer function. Companies in the exosome technologies market are adopting proprietary manufacturing platforms to develop EVs that help to regulate immune responses. They are boosting their production capabilities to develop exosomes that are derived from tumor cells and immune cells, which exhibit unique composition profiles that are directly linked with anti-cancer immunotherapy.

Exosomes hold promising potentials to deliver their cargoes to targeted cells and influence the phenotype and immune-regulation functions of targeted cells. Thus, companies in the exosome technologies market are gaining awareness that exosomes have huge potential in the field of cancer immunotherapy.

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38178

Exosomes Regulate CVD Progression via Exchange of Signal Molecules

Exosomes, also known as extracellular vesicles with a lipid bilayer membrane of endosomal origin have become the focus of a large body of research in cardiovascular diseases (CVD) for companies in the exosome technologies market. These EVs serve as carriers for signal molecules responsible for intracellular and inter-organ communication underlying CVD pathophysiology. Moreover, they help to overcome limitations of the stem cell therapy, since exosomes released by progenitor cells are bioactive and act as key mediators for the stem cell therapy of CVD.

Exosomes play a critical role in cardiovascular pathophysiology, as they help to regulate CVD progression via transport and exchange of signal molecules. For instance, exosomes released by cardiac fibroblasts rescue cardiomyocytes from ischemia-reperfusion injury. 

Report Highlights

In terms of exosome type, the global exosome technologies market has been bifurcated into loaded cargo and non-cargo. The loaded cargo segment dominated the market in 2020. Exosomes carry various types of proteins, lipids, and nucleic acids (mRNA and non-coding RNA). Exosomes with therapeutic cargo help to cross the natural membranous barriers, such as the blood-brain barrier (BBB), to achieve better therapeutic efficiency of brain diseases. This, in turn, is projected to drive the segment.

Based on cell source, the global exosome technologies market has been classified into HEK293, MSCs, platelets, erythrocytes, natural killer cells (NKs), and others. The MSCs segment dominated the global exosome technologies market in 2020, and the trend is anticipated to continue during the forecast period. MSCs have immunomodulatory properties to regulate various cells involved in immune responses and exhibit potent cell therapeutics for various diseases for the last few decades. This factor is expected to propel the segment.

In terms of indication, the global exosome technologies market has been categorized into therapeutics and diagnostics. The diagnostics segment held major share of the global exosome technologies market in 2020. The segment’s dominance can be attributed to reimbursement, availability, and approval of new exosome diagnostics products.

Based on end user, the global exosome technologies market has been divided into healthcare providers, pharmaceutical & biotechnology companies, and others. The healthcare providers segment held a major share of the global exosome technologies market in 2020. The segment’s dominance can be attributed to the increase in the geriatric population suffering from various diseases.

North America is projected to account for prominent share of the global exosome technologies market during the forecast period. Extensive in-house manufacturing & research capacity, large customer base, and a well-established healthcare infrastructure are the major factors driving the market in North America. 

The market in Europe is anticipated to expand at a high CAGR in the near future, owing to strategies adopted by key players and grants of patent for exosomes in the region. 

The exosome technologies market in Asia Pacific is projected to grow at a rapid pace in the near future. This can be attributed to government initiatives to improve healthcare infrastructure. For instance, the Government of Japan and a team of industry players announced a collaboration leveraging exosomes to improve cancer diagnosis and its treatment.

Key Players

Key players operating in the global exosome technologies market are Aegle Therapeutics, Anjarium Biosciences, Aruna Biomedical, Carmine Therapeutics, Ciloa SAS, Codiak BioSciences, Creative Biolabs, Danaher Corporation (Beckman Coulter), Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, Exopharm, Exosome Diagnostics, Inc. (BIO-TECHNE CORPORATION), Fujifilm, ILIAS Biologics, Inc., Illumina, Inc., Invitrix Therapeutics, XOStem, Inc., VivaZome Therapeutics Pty Ltd., Thermo Fisher Scientific, Inc., Organicell, OmniSpirant Ltd., and Novadip Biosciences.

Market Segmentation

By Exosome Type

• Loaded Cargo
  • Peptide
  • siRNA
  • mRNA
  • Protein
  • Chemical
  • Others
• Non-cargo

By Cell Source

• HEK293
• MSCs
• Platelets
• Erythrocytes
• Natural Killer Cells (NKs)
• Others

By Indication

• Therapeutics
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Cosmetics
  • Others
• Diagnostics

By End User

• Healthcare Providers
• Pharmaceutical & Biotechnology Companies
• Others

By Region

• North America
• Europe
• Asia Pacific          
• Latin America
• Middle East & Africa

Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38178

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333